Jan 8, 2025 · Medicare drug plans can now cover Eli Lilly 's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to...

Jan 10, 2025 · Popular Eli Lilly (LLY) weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and Drug Administration (FDA) approval last month.

Jan 9, 2025 · Center for Medicare and Medicaid declared that Zepbound is covered by insurance for treating Sleep Apnea, given it's effectiveness.

2 days ago · Zepbound may be covered under Medicare Part D, which is the prescription drug coverage plan. However, eligibility can depend on specific criteria set by your plan.

Jan 8, 2025 · Zepbound met that new criteria last month after the FDA approved it as the first prescription medication to address moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It...

Jan 9, 2025 · The Centers for Medicare and Medicaid Services on Wednesday confirmed that certain Medicare plans can now cover the use of Eli Lilly ’s blockbuster obesity drug Zepbound (tirzepatide) for use in obstructive sleep apnea, according to CNBC.

Medicare drug plans are now allowed to cover Eli Lilly’s blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC on...

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment.

Jan 9, 2025 · Eli Lilly's obesity drug Zepbound (tirzepatide) can now be covered by Medicare insurance plans for use in sleep apnea, broadening access to the weight-loss treatment.

3 days ago · Generally, Medicare Part D plans may cover Zepbound if it is deemed medically necessary and prescribed by a healthcare provider. However, not all plans are created equal, and some may have restrictions or require prior authorization before covering the medication.